Glucose monitor begins clinical trials. The device is being evaluated within a system of care that includes home use of the Diasensor and regular evaluation of a patient's blood glucose. The device automatically transmits glucose readings to a secure Web site where they can be viewed by patients' healthcare providers. Blood test for lung cancer nearing reality. A new study, presented at the annual congress of the American College of Surgeons, finds a potential marker in bone marrow that may help doctors detect lung cancer with a simple blood test.
Fibrinogen test better indicator of heart disease than gold standard.
Functional Intact Fibrinogen test demonstrates a stronger association with cardiovascular disease than the Clauss method, the current gold standard. Inc. All rights reserved.